Behcet Syndrome

25 registered clinical trials studyying Behcet Syndrome — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone NCT06780462	Assistance Publique - Hôpitaux de Paris	Phase 3
Unknown	Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers NCT04186559	Silk Road Therapies, Inc.	Phase 2
Completed	Upadacitinib for Refractory Behcet's Syndrome NCT07080346	Liu Tian	Phase 2
Recruiting	Evaluation of Serum Follistatin-Like Protein 1 Levels in Behcet's Disease and Its Association With Disease Act NCT06730958	Assiut University	—
Recruiting	Pan-immune-inflammation Value (PIN) in Behçet's Disease and Its Correlation With Disease Activity NCT06729112	Assiut University	—
Completed	Sleep Related Breathing Disorders, Anxiety, Depression and Quality of Life Assessment in Behcet's Disease NCT05142995	Assiut University	—
Unknown	Neuro-ultrasound Assessment in Behcet's Disease NCT04738864	Assiut University	N/A
Completed	Zinc Supplementation and Behçet's Syndrome NCT05098678	Tabriz University of Medical Sciences	N/A
Recruiting	AutoInflammatory Disease Alliance Registry (AIDA) NCT05200715	University of Siena	—
Terminated	Golimumab for the Treatment of Refractory Behcet's Uveitis NCT04218565	Wenjie Zheng	Phase 2
Completed	Erectile Dysfunction in Patients With Non Ocular Behçet's Disease NCT04386824	Antalya Training and Research Hospital	—
Unknown	Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease NCT03771768	Cairo University	N/A
Completed	Uses of Tacrolimus in Behcet Disease NCT05032248	Assiut University	N/A
Completed	Gut Microbiota and Behcet's Syndrome: a Dietary Intervention Trial (MAMBA Study) NCT03962335	Azienda Ospedaliero-Universitaria Careggi	N/A
Unknown	Assessment of Disease Activity in Behcet by Complete Blood Count NCT03747354	Assiut University	N/A
Completed	Frequency of Fibromyalgia in Behcet Disease NCT03514056	Bursa Yuksek Ihtisas Training and Research Hospital	—
Terminated	Tocilizumab for the Treatment of Refractory Behcet's Uveitis NCT03554161	Wenjie Zheng	Phase 2
Completed	Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography NCT03264391	Assiut University	—
Completed	Dietary Interventions and Butyrate Production in Behçet's Patients NCT03274648	Azienda Ospedaliero-Universitaria Careggi	N/A
Completed	Evaluation of the Psychoeducation Program Given to Behcet's Patients in the Context of the Roy Adaptation Mode NCT04961463	Ulucanlar Eye Training and Research Hospital	N/A
Terminated	Tocilizumab for the Treatment of Behcet's Syndrome NCT01693653	NYU Langone Health	Phase 2
Completed	Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions NCT01532570	Tanabe Pharma Corporation	Phase 3
Unknown	Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease NCT00931957	Tehran University of Medical Sciences	N/A
Completed	A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease NCT00866359	Amgen	Phase 2
Completed	Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease NCT00483184	Nobel Pharmaceuticals	Phase 2